{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:39:28Z","timestamp":1776796768943,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.08.039","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:17:42Z","timestamp":1567790262000},"page":"6535-6542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-2369","authenticated-orcid":false,"given":"Jing-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chin","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chienjin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maw-Sheng","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.039_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","article-title":"Concurrent infections are important for expression of porcine circovirus associated disease","volume":"164","author":"Opriessnig","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.08.039_b0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.prevetmed.2013.02.010","article-title":"Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England \u2013 an economic disease model","volume":"110","author":"Alarcon","year":"2013","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2019.08.039_b0015","first-page":"1","article-title":"Best practice and future challenges for vaccination against porcine circovirus type 2","volume":"14","author":"Segal\u00e9s","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.08.039_b0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.08.039_b0025","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1128\/JVI.02345-12","article-title":"Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0030","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s00705-014-2164-6","article-title":"Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea","volume":"159","author":"Seo","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vetmic.2015.01.013","article-title":"Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany","volume":"176","author":"Eddicks","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0040","doi-asserted-by":"crossref","first-page":"39458","DOI":"10.1038\/srep39458","article-title":"Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: a large scale epidemiological study","volume":"6","author":"Franzo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.08.039_b0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetmic.2016.11.009","article-title":"PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014\u20132016","volume":"197","author":"Xiao","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virusres.2016.11.015","article-title":"Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population","volume":"228","author":"Kwon","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.08.039_b0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vetmic.2014.05.028","article-title":"Comparison of sow and\/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge","volume":"172","author":"Oh","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vaccine.2016.11.085","article-title":"A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to na\u00efve pigs under experimental conditions","volume":"35","author":"Opriessnig","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.039_b0065","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1111\/tbed.12768","article-title":"Phylogenetic and genetic variation analyses of porcine circovirus type 2 isolated from China","volume":"65","author":"Yang","year":"2018","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.08.039_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: iss eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/v9050099","article-title":"Porcine circovirus type 2 (PCV2) vaccines in the context of current molecular epidemiology","volume":"9","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.08.039_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/v9040086","article-title":"Classical swine fever \u2013 an updated review","volume":"9","author":"Blome","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.08.039_b0085","article-title":"Effects of vaccination with the C-strain vaccine on immune cells and cytokines of pigs against classical swine fever virus","author":"Xu","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0090","doi-asserted-by":"crossref","first-page":"e29310","DOI":"10.1371\/journal.pone.0029310","article-title":"Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity","volume":"7","author":"Graham","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.08.039_b0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0378-1135(88)90036-3","article-title":"The protective value of vaccine-induced neutralising antibody titres in swine fever","volume":"16","author":"Terpstra","year":"1988","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vetmic.2003.09.008","article-title":"Vaccinology of classical swine fever: from lab to field","volume":"96","author":"van Oirschot","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-1135(03)00158-5","article-title":"Infection of porcine reproductive and respiratory syndrome virus suppresses the antibody response to classical swine fever virus vaccination","volume":"95","author":"Li","year":"2003","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0110","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2005.12.010","article-title":"Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine","volume":"24","author":"Suradhat","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.039_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2006.10.003","article-title":"Factors critical for successful vaccination against classical swine fever in endemic areas","volume":"119","author":"Suradhat","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vetmic.2016.11.007","article-title":"Up-regulation of IL-10 upon PRRSV vaccination impacts on the immune response against CSFV","volume":"197","author":"Wang","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tvjl.2012.06.029","article-title":"Subclinical porcine circovirus infection: what lies beneath","volume":"194","author":"Maes","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.08.039_b0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/104063870401600214","article-title":"Interlaboratory testing of porcine sera for antibodies to porcine circovirus type 2","volume":"16","author":"McNair","year":"2004","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2019.08.039_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/104063871102300203","article-title":"Interlaboratory comparison of porcine circovirus-2 indirect immunofluorescent antibody test and enzyme-linked immunosorbent assay results on experimentally infected pigs","volume":"23","author":"Patterson","year":"2011","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2019.08.039_b0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1051\/vetres:2005024","article-title":"Reproduction of PMWS in immunostimulated SPF piglets transfected with infectious cloned genomic DNA of type 2 porcine circovirus","volume":"36","author":"Grasland","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.08.039_b0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/jcpa.1999.0337","article-title":"Reproduction of lesions of postweaning multisystemic wasting syndrome by infection of conventional pigs with porcine circovirus type 2 alone or in combination with porcine parvovirus","volume":"122","author":"Kennedy","year":"2000","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.prevetmed.2010.11.015","article-title":"A meta-analysis comparing the effect of PCV2 vaccines on average daily weight gain and mortality rate in pigs from weaning to slaughter","volume":"98","author":"Kristensen","year":"2011","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2019.08.039_b0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2014.02.002","article-title":"Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines","volume":"200","author":"Seo","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.08.039_b0165","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/CVI.00768-13","volume":"21","author":"Park","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.vetmic.2014.05.003","article-title":"Can Porcine circovirus type 2 (PCV2) infection be eradicated by mass vaccination?","volume":"172","author":"Feng","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40813-017-0053-6","article-title":"The use of vaccines to control pathogen spread in pig populations","volume":"3","author":"Rose","year":"2017","journal-title":"Porc Health Manag"},{"key":"10.1016\/j.vaccine.2019.08.039_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/1297-9716-42-115","article-title":"Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine","volume":"42","author":"Huang","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.08.039_b0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2004.08.014","article-title":"Quantitation of porcine circovirus type 2 isolated from serum\/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR","volume":"122","author":"Brunborg","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.08.039_b0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","article-title":"Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs","volume":"125","author":"Fort","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vetmic.2008.10.007","article-title":"Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark","volume":"135","author":"Grau-Roma","year":"2009","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.08.039_b0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1751-0147-52-22","article-title":"Dynamics of serum antibodies to and load of porcine circovirus type 2 (PCV2) in pigs in three finishing herds, affected or not by postweaning multisystemic wasting syndrome","volume":"52","author":"Brunborg","year":"2010","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.vaccine.2019.08.039_b0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/104063871102300206","article-title":"Theoretical and experimental approaches to estimate the usefulness of pooled serum samples for the diagnosis of postweaning multisystemic wasting syndrome","volume":"23","author":"Cortey","year":"2011","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2019.08.039_b0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","article-title":"Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis","volume":"164","author":"Segal\u00e9s","year":"2012","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:19Z","timestamp":1759401439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1931103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0264410X1931103X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}